Rocco Matías, Rada Gabriel
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.
Proyecto Epistemonikos, Santiago, Chile; Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro Evidencia UC, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; The Cochrane Collaboration; GRADE working group. Email:
Medwave. 2018 Feb 14;18(1):e7154. doi: 10.5867/medwave.2018.01.7153.
Cannabinoids have been proposed as a therapeutic alternative for fibromyalgia. However, their clinical effectiveness is a matter of debate.
To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies and generated a summary of findings table using the GRADE approach.
We identified fifteen systematic reviews including two randomized trials overall. We concluded it is not clear whether cannabinoids have any benefit in fibromyalgia because the certainty of the evidence is very low. On the other hand, they are associated to frequent adverse effects.
大麻素已被提议作为纤维肌痛的一种治疗选择。然而,其临床疗效存在争议。
为回答这个问题,我们使用了Epistemonikos,这是最大的健康领域系统评价数据库,通过筛选多个信息来源进行维护,包括MEDLINE、EMBASE、Cochrane等。我们从系统评价中提取数据,重新分析了原始研究的数据,并使用GRADE方法生成了结果总结表。
我们共识别出15项系统评价,总体包括两项随机试验。我们得出结论,由于证据的确定性非常低,目前尚不清楚大麻素对纤维肌痛是否有任何益处。另一方面,它们与频繁的不良反应相关。